Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response. Read more about Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response.
Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer. Read more about Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer.
Discovery of highly selective inhibitors of calmodulin-dependent kinases that restore insulin sensitivity in the diet-induced obese in vivo mouse model. Read more about Discovery of highly selective inhibitors of calmodulin-dependent kinases that restore insulin sensitivity in the diet-induced obese in vivo mouse model.
Mitochondrial uncoupling protein-dependent signaling in plant bioenergetics and stress response. Read more about Mitochondrial uncoupling protein-dependent signaling in plant bioenergetics and stress response.
Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma. Read more about Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma.
HighVia-A Flexible Live-Cell High-Content Screening Pipeline to Assess Cellular Toxicity. Read more about HighVia-A Flexible Live-Cell High-Content Screening Pipeline to Assess Cellular Toxicity.
Bioisosteric Replacement of Arylamide-linked Spine Residues by N-Acylhydrazones and Selenophenes as Design Strategy to Novel Dibenzosuberone Derivatives as Type I½ p38 MAP Kinase Inhibitors. Read more about Bioisosteric Replacement of Arylamide-linked Spine Residues by N-Acylhydrazones and Selenophenes as Design Strategy to Novel Dibenzosuberone Derivatives as Type I½ p38 MAP Kinase Inhibitors.
Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases. Read more about Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases.
STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers. Read more about STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers.
Structural Basis for the Binding Selectivity of Human CDY Chromodomains. Read more about Structural Basis for the Binding Selectivity of Human CDY Chromodomains.
